Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

50.0%

6 terminated/withdrawn out of 12 trials

Success Rate

45.5%

-41.0% vs industry average

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results5 withdrawn

Enrollment Performance

Analytics

N/A
8(66.7%)
Phase 4
3(25.0%)
Phase 2
1(8.3%)
12Total
N/A(8)
Phase 4(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)